Today news
About the same in other media
Tether Invests $200 Million in Blackrock Neurotech’s Neurological Disorder Solutions
Reading now: 367
Tether, the issuer of the USDT stablecoin, has made a groundbreaking move in the healthcare sector with a strategic $200 million investment in Blackrock Neurotech, a leading biotech company specializing in brain-computer interface (BCI) technology.
Through its new venture division , Tether Evo, the stablecoin giant, has become the majority stakeholder in Blackrock Neurotech, signaling a significant step towards advancing medical solutions for individuals affected by paralysis, neurological disorders, and lost function.
Today Tether takes the majority stake in @BlackrockNeuro_ and unveils the ultimate pillar of its long term vision and strategy: Tether Evo
Read more on cryptonews.comAbout this in other media
VanEck’s Bitcoin ETF Gains $109 Million Net Asset, Holds $619 Million Bitcoin in Q1 cryptonews.com /6 months ago
Tether CEO Calls Out Ripple Chief for Inciting Panic About USDT cryptonews.com /6 months ago
Wells Fargo Banks Has Invested $143 Million In Bitcoin, Filing Reveals cryptonews.com /6 months ago
Show more
The website finance-news.co. is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
